Motion Sickness

Add Info

Motion Sickness Recall

Get an alert when a recall is issued.

Ask a Question

Questions & Answers

Add Info

Side Effects & Adverse Reactions

If pregnant or nursing, consult a practitioner before using.

Add Info

Legal Issues

There is currently no legal information available for this drug.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

Indications: To be used for acute self-limiting conditions according to standard homeopathic indications

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

There are no additional details available for this product.

Sources

Motion Sickness Manufacturers

Natural Health Supply

Motion Sickness | Natural Health Supply

Take at onset of symptoms. Repeat every 2 hours or as needed until relieved. If condition persists or worsens discontinue use and consult a practitioner.

Adults: dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth. Children and infants: 1-5 pellets.

No Recall
Target Corporation

Motion Sickness | Target Corporation

to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity adults and children 12 years of age and over: 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years of age: 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years of age: 1/2 tablet every 6-8 hours; not to exceed 1 1/2 tablets in 24 hours, or as directed by a doctor

No Recall
Hyland’s

Motion Sickness | Hyland's

adults Dissolve 2 to 3 tablets in mouth every 4 hours or as needed. Use no more than 6 times per day. children 6 to 12 years 1/2 adult dose.

No Recall
Newton Laboratories, Inc.

Motion Sickness | Newton Laboratories, Inc.

Directions: ORAL USE ONLY - SHAKE WELL. Ages 12 and up, take 6 drops orally (ages 0 to 11, give 3 drops) as needed or as directed by a healthcare professional. Sensitive persons begin with 1 drop and gradually increase to full dose.

No Recall
Liddell Laboratories, Inc.

Motion Sickness | Marnel Pharmaceuticals, Llc

One or two capsules every four hours. Total daily dosage should not exceed 6 capsules.

Extended and repeated use of this product is not recommended because of the potential for physical dependence.

No Recall
Newton Laboratories, Inc.

Motion Sickness | Newton Laboratories, Inc.

Directions: Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) as needed or as directed by a healthcare professional. Under age 2, crush or dissolve pellets in purified water. Sensitive persons begin with 1 pellet and gradually increase to full dose.

No Recall
The Kroger Co.

Motion Sickness | The Kroger Co.

to prevent motion sickness, the first dose should be taken 1 hour before starting activity adults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor do not exceed 2 tablets in 24 hours

No Recall
Premier Value (Chain Drug Consortium, Llc)

Motion Sickness | Chain Drug Consortium, Llc

to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity adults and children 12 years and over 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years 1/4 to 1/2 tablet every 6-8 hours; not to exceed 1-1/2 tablets in 24 hours, or as directed by a doctor

No Recall
Freds Inc

Motion Sickness | Freds Inc

to prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity a dults and children 12 years and over 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years 1/4 to 1/2 tablet every 6-8 hours; not to exceed 1-1/2 tablets in 24 hours, or as directed by a doctor

No Recall
Meijer, Inc.

Motion Sickness | Meijer, Inc.

to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity adults and children 12 years and over 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years 1/4 to 1/2 tablet every 6-8 hours; not to exceed 1-1/2 tablets in 24 hours, or as directed by a doctor

No Recall
Hy-vee

Motion Sickness | Hy-vee

to prevent motion sickness, the first dose should be taken 1 hour before starting activity adults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor do not exceed 2 tablets in 24 hours

No Recall
Great Lakes Wholesale, Marketing, & Sales, Inc.

Motion Sickness | Great Lakes Wholesale, Marketing, & Sales, Inc.

to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity adults and children 12 years of age and over: 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years of age: 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years of age: 1/2 tablet every 6-8 hours; not to exceed 1 1/2 tablets in 24 hours, or as directed by a doctor

No Recall
Top Care (Topco Associates Llc)

Motion Sickness | Top Care (topco Associates Llc)

to prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity adults and children 12 years and over 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours or as directed by a doctor children 6 to under 12 years ½ to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours or as directed by a doctor children 2 to under 6 years ¼ to ½ tablet every 6-8 hours; not to exceed 1-½ tablets in 24 hours or as directed by a doctor

No Recall
Woonsocket Prescription Center,incorporated

Motion Sickness | Bausch & Lomb Incorporated

Adults: Instill one or two drops of 1% solution in the eye which may be repeated in five to ten minutes if necessary. Complete recovery usually occurs in 24 hours. Complete recovery from mydriasis in some individuals may require several days.

Children: Instill one or two drops of 1% solution in the eye, which may be repeated five to ten minutes later by a second application of 1% solution if necessary.

Individuals with heavily pigmented irises may require higher strengths.

No Recall
Stephen L. Lafrance Pharmacy, Inc.

Motion Sickness | Emd Serono, Inc.

Serostim® is administered by subcutaneous injection.

Serostim® therapy should be carried out under the regular guidance of a physician who is experienced in the diagnosis and management of HIV infection.
2.1 HIV-associated wasting or cachexia
The usual starting dose of Serostim® is 0.1 mg/kg subcutaneously once daily (up to a total dose of 6 mg). Serostim® should be administered subcutaneously once daily at bedtime according to the following body weight-based dosage recommendations:
Weight Range Dose * Based on an approximate daily dosage of 0.1 mg/kg. >55kg (>121 lb) 6 mg* SC daily 45-55 kg (99-121 lb) 5 mg* SC daily 35-45 kg (75-99 lb) 4 mg* SC daily <35 kg (<75 lb) 0.1 mg/kg SC daily
Treatment with Serostim® 0.1 mg/kg every other day was associated with fewer side effects, and resulted in a similar improvement in work output, as compared with Serostim® 0.1 mg/kg daily. Therefore, a starting dose of Serostim® 0.1 mg/kg every other day should be considered in patients at increased risk for adverse effects related to recombinant human growth hormone therapy (i.e., glucose intolerance). In general, dose reductions (i.e., reducing the total daily dose or the number of doses per week) should be considered for side effects potentially related to recombinant human growth hormone therapy.

Most of the effect of Serostim® on work output and lean body mass was apparent after 12 weeks of treatment. The effect was maintained during an additional 12 weeks of therapy. There are no safety or efficacy data available from controlled studies in which patients were treated with Serostim® continuously for more than 48 weeks. There are no safety or efficacy data available from trials in which patients with HIV wasting or cachexia were treated intermittently with Serostim®.
2.2 Preparation and Administration
Each vial of Serostim® 5 mg or 6 mg is reconstituted with 0.5 to 1 mL Sterile Water for Injection, USP.

Each vial of Serostim® 4 mg is reconstituted in 0.5 to 1 mL of Bacteriostatic Water for Injection, USP (0.9% Benzyl Alcohol preserved). For patients sensitive to Benzyl Alcohol, Serostim® may be reconstituted with Sterile Water for Injection, USP [see Pediatric Use (8.4)].

When Serostim® is reconstituted with Sterile Water for Injection, USP, the reconstituted solution should be used immediately and any unused portion should be discarded.

When Serostim® is reconstituted with Bacteriostatic Water for Injection, USP (0.9% Benzyl Alcohol preserved) the reconstituted solution may be refrigerated (2-8°C/36-46°F) for up to 14 days.

Approximately 10% mechanical loss can be associated with reconstitution and administration from multi-dose vials.

To reconstitute Serostim®, inject the diluent into the vial of Serostim® aiming the liquid against the glass vial wall. Swirl the vial with a GENTLE rotary motion until contents are dissolved completely. DO NOT SHAKE. Parenteral drug products should always be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. SEROSTIM® MUST NOT BE INJECTED if the solution is cloudy or contains particulate matter. Use it only if it is clear and colorless.

Serostim® can be administered using (1) a standard sterile, disposable syringe and needle, (2) a compatible Serostim® needle-free injection device or (3) a compatible Serostim® needle injection device. For proper use, refer to the Instructions for Use provided with the administration device.

Injection sites, which may be located on the thigh, upper arm, abdomen or buttock, should be rotated to avoid local irritation.

No Recall